TOKYO - A Japanese scientist called on Monday for withdrawing stem-cell research he had been involved in that had appeared to promise a new era of medical biology as doubts have arisen over the results.
CAPE CANAVERAL, Fla - Japanese astronaut Koichi Wakata assumed command of the International Space Station on Sunday, the first Japanese national to oversee a manned space mission.
OSLO - Scientists have detected four new man-made gases that damage the Earth's protective ozone layer, despite bans on almost all production of similar gases under a 1987 treaty, a study showed on Sunday.
SYDNEY - It may sound like science fiction but an Australian team is working on a project to zap orbital debris with lasers from Earth to reduce the growing amount of space junk that threatens to knock out satellites with a "cascade of collisions".
BRUSSELS - EU scientists have found that the new car coolant at the centre of a dispute that has pitched regulators against Germany and its luxury carmaker Daimler does not pose any serious safety risks, the European Commission said on Friday.
JERUSALEM - It's only the size of a dishwasher and weighs as much as giant panda, but its inventors are hoping this spacecraft will go where no other Israeli vessel has gone before - to the moon.
CAPE CANAVERAL, Florida - About 5 million years ago, an asteroid or comet slammed into Mars so hard that rocks and other debris launched into space.
WASHINGTON - Patsy Cline's classic country song "I Fall to Pieces," has nothing on this one.
ROME - Sicilian amateur scientists have launched a model cannolo, a cream-stuffed pastry roll symbolic of the Italian island, into the stratosphere, capturing bizarre images of the dessert flying far above the earth.
CAPE CANAVERAL, Florida - A supermassive black hole inside a distant quasar spins at about 336 million mph (540 million kph) or roughly half the speed of light, according to research published on Wednesday in the journal Nature.
- German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy.